189 related articles for article (PubMed ID: 24549751)
1. The pituitary stalk effect: is it a passing phenomenon?
Bergsneider M; Mirsadraei L; Yong WH; Salamon N; Linetsky M; Wang MB; McArthur DL; Heaney AP
J Neurooncol; 2014 May; 117(3):477-84. PubMed ID: 24549751
[TBL] [Abstract][Full Text] [Related]
2. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia in a male pituitary androgen receptor knockout mouse is associated with female-like lactotroph development.
O'Hara L; Christian HC; Le Tissier P; Smith LB
Andrology; 2021 Sep; 9(5):1652-1661. PubMed ID: 33998165
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the stalk effect: a new hypothesis explaining suprasellar tumor-induced hyperprolactinemia.
Skinner DC
Med Hypotheses; 2009 Mar; 72(3):309-10. PubMed ID: 19028420
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome.
Kruse A; Astrup J; Gyldensted C; Cold GE
Br J Neurosurg; 1995; 9(4):453-7. PubMed ID: 7576271
[TBL] [Abstract][Full Text] [Related]
6. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Disconnection Hyperprolactinemia and Reversal of Serum Prolactin after Pituitary Surgery in a Non-Functioning Pituitary Macroadenoma.
Kumran T; Haspani S; Malin Abdullah J; Alias A; Ven FR
Malays J Med Sci; 2016 Jan; 23(1):72-6. PubMed ID: 27540328
[TBL] [Abstract][Full Text] [Related]
8. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.
Arafah BM; Prunty D; Ybarra J; Hlavin ML; Selman WR
J Clin Endocrinol Metab; 2000 May; 85(5):1789-93. PubMed ID: 10843153
[TBL] [Abstract][Full Text] [Related]
9. Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in long-standing primary hypothyroidism.
Pioro EP; Scheithauer BW; Laws ER; Randall RV; Kovacs KT; Horvath E
Surg Neurol; 1988 Mar; 29(3):218-26. PubMed ID: 3344469
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.
Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
Front Endocrinol (Lausanne); 2021; 12():807054. PubMed ID: 35154007
[TBL] [Abstract][Full Text] [Related]
11. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ
J Clin Invest; 2002 Oct; 110(7):973-81. PubMed ID: 12370275
[TBL] [Abstract][Full Text] [Related]
12. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
13. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
15. Suprasellar craniopharyngioma associated with hyperprolactinemia, pituitary lactotroph hyperplasia, and microprolactinoma. Case report.
Cusimano MD; Kovacs K; Bilbao JM; Tucker WS; Singer W
J Neurosurg; 1988 Oct; 69(4):620-3. PubMed ID: 3418397
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome.
Lees PD; Pickard JD
J Neurosurg; 1987 Aug; 67(2):192-6. PubMed ID: 3598680
[TBL] [Abstract][Full Text] [Related]
17. Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excess.
Wynne AG; Scheithauer BW; Young WF; Kovacs K; Ebersold MJ; Horvath E
Neurosurgery; 1992 Jun; 30(6):919-23. PubMed ID: 1319562
[TBL] [Abstract][Full Text] [Related]
18. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
20. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
